Reddit Posts
there have been so many plays last few weeks but everyone keeps hyping negg?
tickers squeezes with $VVOS - $YOSH, $CYTO
Feetr Data Dump: ATXI CREV RDHL VVOS WHLR YOSH Post image
Vivos Therapeutics (NASDAQ: VVOS) - Awaiting a Significant Breakout & Positive Cash Flow! 💰💹
Feetr Data Dump: TRKA AMC LHDX HLBZ VVOS ONCS LION
Biotechs Moving in the Pre-Market: $VVOS, $CUBT, $ORTX, $VYNT, $VYNE
Biotechs Moving in the Pre-Market: $VVOS, $CUBT, $ORTX, $VYNT, $VYNE
VVOS stock up 100 % in premarket after new news (news in Link)
Sleep stocks, specifically sleep apnea stocks, will do quite well the next decade.
Sleep stocks, specifically sleep apnea stocks, will do quite well the next decade.
Sleep stocks, specifically sleep apnea stocks, will do quite well the next decade.
Sleep stocks, specifically sleep apnea stocks, will do quite well the next decade.
Sleep stocks, specifically sleep apnea stocks, will do quite well the next decade.
Overlooked Stocks Video SBEV GMVD VVOS by TDAmeritrade YT channel
Overlooked Stocks: SBEV, GMVD, VVOS by TD Ameritrade YouTube channel
Overlooked Stocks: SBEV, GMVD, VVOS by TD Ameritrade YouTube channel
Where's my snorers at? The bullish case for sleep apnea stocks.
Vivos Therapeutics (VVOS) - FDA approved VVOS sleep apnea device
Mentions
VVOS is double digits gains in the green for 6 tradings days straight. Low float and not on the radar of retail. It’s a 10 bagger, DD
A sea of red and there is VVOS a beacon of GREEN
I am big on VVOS, MBOT and RGDL as well.
According to GPT with references: ^[The comment regarding VivoPower International PLC (NASDAQ: VVPR) having warrants exercisable at $13 and the implications for dilution warrants a detailed examination.]({"attribution":{"attributableIndex":"0-0"}}) [oai_citation:0‡VivoPower |](https://vivopower.com/wp-content/uploads/2022/09/220928-VVPR-FY2022-Annual-Report.pdf?utm_source=chatgpt.com) ### 🔍 Understanding VVPR's Warrants and Potential Dilution **1. Existing Warrants:** - **Series A Warrants:** ^[In July 2022, VivoPower issued 4,230,770 Series A Warrants with an exercise price of $1.30 per share. These warrants became exercisable six months post-issuance and have a five-year term, expiring in February 2028.]({"attribution":{"attributableIndex":"169-3"}}) [oai_citation:1‡VivoPower |](https://vivopower.com/wp-content/uploads/2022/09/220928-VVPR-FY2022-Annual-Report.pdf?utm_source=chatgpt.com) - **Pre-Funded Warrants:** ^[Alongside the Series A Warrants, 1,930,770 pre-funded warrants were issued at an offering price of $1.2999 per warrant, with an exercise price of $0.0001 per share. These are exercisable immediately and remain so until fully exercised.]({"attribution":{"attributableIndex":"521-1"}}) [oai_citation:2‡VivoPower |](https://vivopower.com/wp-content/uploads/2022/09/220928-VVPR-FY2022-Annual-Report.pdf?utm_source=chatgpt.com) **2. $13 Warrants:** ^[There is no publicly available information or SEC filings indicating the existence of VVPR warrants with a $13 exercise price.]({"attribution":{"attributableIndex":"808-1"}}) ^[The previously issued warrants have significantly lower exercise prices, as detailed above.]({"attribution":{"attributableIndex":"808-2"}}) **3. Dilution Implications:** ^[The exercise of existing warrants would lead to the issuance of additional shares, thereby diluting the holdings of existing shareholders.]({"attribution":{"attributableIndex":"1055-1"}}) ^[However, the extent of dilution depends on the number of warrants exercised and the total shares outstanding.]({"attribution":{"attributableIndex":"1055-2"}}) [oai_citation:3‡Stock Titan](https://www.stocktitan.net/news/VVOS/vivos-therapeutics-announces-exercise-of-warrants-for-approximately-4kalixtsjk4k.html?utm_source=chatgpt.com) ### 📈 Current Share Structure: - **Shares Outstanding:** ^[Approximately 3.08 million shares.]({"attribution":{"attributableIndex":"1341-2"}}) - **Float:** ^[Approximately 1.39 million shares.]({"attribution":{"attributableIndex":"1458-1"}}) [oai_citation:4‡X (formerly Twitter)](https://twitter.com/ProfitGrand/status/1787515053912027455?utm_source=chatgpt.com) - **Insider Ownership:** ^[Approximately 43%.]({"attribution":{"attributableIndex":"1530-1"}}) [oai_citation:5‡X (formerly Twitter)](https://twitter.com/ProfitGrand/status/1787515053912027455?utm_source=chatgpt.com) ### 🧠 Conclusion: ^[The assertion that VVPR has warrants exercisable at $13 is not supported by available data.]({"attribution":{"attributableIndex":"1598-1"}}) ^[The existing warrants have exercise prices of $1.30 and $0.0001, respectively.]({"attribution":{"attributableIndex":"1598-2"}}) ^[While the exercise of these warrants would result in dilution, the impact is contingent upon the number of warrants exercised relative to the total shares outstanding.]({"attribution":{"attributableIndex":"1598-3"}}) [oai_citation:6‡VivoPower |](https://vivopower.com/wp-content/uploads/2022/09/220928-VVPR-FY2022-Annual-Report.pdf?utm_source=chatgpt.com) ^[It's crucial for investors to monitor official SEC filings and company announcements for the most accurate and up-to-date information regarding share structure and potential dilution.]({"attribution":{"attributableIndex":"1964-0"}}) ---
Good news for companies in the sector of OSA treatments, $VVOS is starting to take momentum, like the last 2 decembers. Worth a watch into the sector, as someone with sleep apnea
VVOS makes a x5 +/- every christmas before falling again
Any word? I looked them up and found another company with almost the same name. RDGL is Vivos Inc. VVOS is Vivos Therapeutics. Hard to tell what is what. RDGL has cancer treatment gel and VVOS has a sleep apnea device.
If day the same regarding GLP-1s. Even healthy/skinny people are getting sleep apnea more. I've read that there is a link to childhood food changes that have altered the development of our jaw muscles....which means that it's going to be a long running trend. There's other companies working on treatment. VVOS has a retainer like device that's sold through dentists. There's also a surgical option, but that's only for extreme cases and is very expensive. I forget the name of the company that does it, bit they're publicly traded. This is one that reminds of of Cintas or.one of those companies. It's such a good business for so long, and not really cyclical, that we just forget how good it really is.
Here you are: VVOS: Vivos Therapeutics, Inc. (VVOS) is currently trading at $2.63, with technical indicators suggesting a neutral to slightly bullish sentiment. The 10-day SMA at $2.50 and the 20-day EMA at $2.60 indicate potential support, while the MACD histogram shows a slight positive divergence, hinting at possible upward momentum. However, the RSI levels are hovering around 50, indicating neither overbought nor oversold conditions, which suggests limited immediate upside. Given the broader market's cautious optimism and VVOS's low volume, expect range-bound trading with potential resistance near $2.70. For day trading, consider entering around $2.60, targeting $2.68 as the first price target with moderate confidence, and $2.75 as the second target with lower confidence due to lack of strong catalysts. Set a stop loss at $2.55 to manage downside risk. Overall, the stock may see modest gains if it aligns with broader market strength, but remain vigilant for any unexpected news or shifts in market sentiment. LTBR: Lightbridge Corp. (LTBR) has shown significant upward momentum, with the current price at $7.32, well above its 10-day SMA of $4.89 and 20-day EMA of $4.44, indicating strong bullish sentiment. The RSI levels are nearing overbought territory, suggesting potential for a short-term pullback, but the MACD histogram remains positive, supporting continued upward movement. Recent high trading volumes, particularly the spike to over 9 million shares, suggest increased investor interest, possibly driven by undisclosed catalysts. Given the broader market's cautious optimism, LTBR may benefit from the tech sector's strength, though it remains somewhat detached from major indices trends. For today's session, consider entering around $7.30, with a first target of $8.00 and a second target of $8.50, while setting a stop loss at $6.80 to manage downside risk. Confidence in reaching the first target is moderate due to strong technical indicators, while the second target carries lower confidence given potential resistance and market volatility. Stay vigilant for any news developments that could impact momentum. RCAT: Red Cat Holdings, Inc. (RCAT) is currently trading at $2.85, showing a bearish trend with the 6-day RSI at 34, indicating potential oversold conditions. The stock has been on a downward trajectory, breaking below its 10-day SMA of $3.23 and 20-day EMA of $3.10, suggesting continued selling pressure. The MACD histogram is negative, reinforcing the bearish sentiment. Given the lack of recent news and current market dynamics, RCAT may face further downside unless a catalyst emerges. For today's session, consider entering a short position around $2.90, with a first price target of $2.70 and a second target of $2.50. Set a stop loss at $3.00 to manage risk. Confidence in reaching the first target is moderate due to technical indicators, while the second target carries lower confidence given potential volatility. HOVR: New Horizon Aircraft Ltd. (HOVR) is currently trading at $0.35, showing signs of consolidation after a volatile period. The 10-day SMA at $0.3258 suggests short-term support, while the 20-day SMA at $0.3528 indicates potential resistance. The RSI levels are below 50, reflecting weak momentum and possible further downside. The MACD histogram is positive but close to zero, indicating limited bullish momentum. Given the broader market's cautious optimism and HOVR's low volume, expect a range-bound session with potential for a slight pullback. Enter a short position around $0.35, targeting $0.33 as the first price target and $0.31 as the second, with a stop loss at $0.37. Confidence in reaching the first target is moderate due to weak momentum, while the second target has lower confidence given potential support at the 10-day SMA.
I’m in VVOS and XXII. Don’t ask me why but I’ve make 21k this week so I got money to lose. AMC gains not shown but I paper handed and only made 3 stacks https://preview.redd.it/npgf2kunho0d1.png?width=1044&format=png&auto=webp&s=9d4020a8c17db3683ce616ed0d9ef8fe468a991d
Windtree isn't Chinese, it's American. Lee Pharmaceuticals is the partner, and their HQ is Hong Kong. With that being said, this deal is exclusive to China. Windtree still owns everything outside those borders. It will also put money in their pocket and help fast track them in the market most affected by heart failure (while giving them double-digit royalties), as Lee's is taking on the R&D for a Phase 3 of Windtree's top candidate. This space hasn't been disrupted in years. If this is successful, we're talking about a VVOS-type move, with the potential for even more. That's not a tomorrow thing, but it will happen when the time comes.
VVOS. They are truly going places. They only have ~40,000 users so far, so the potential is not on anyone's radar yet. I bought shares at $1 each after 6 months of using the product and realizing how great they are, and the price shot up to almost $50 per share a couple weeks ago. They are still a very small capital company too, around 5-20mil, and they just got a landmark FDA approval and signed multiple distribution deals for USA and Africa/Middle East.
VVOS is another FDA Approval play with further potential upside.
Anyone got a a thought on VVOS? I know it had a crazy run up last week. Is it on it's way down to stay down or jumping back up again at some point? NFA I know. TIA!
Thanks for replying. I think I got myself in a soup with trying to be greedy. Having seen the runups of VVOS and IXHL past 2 days, I felt this could do the same, and ended up buying worth $2k. Hopefully it doesn’t all become zero atleast. 😑
Thanks for replying. I think I got myself in a soup with trying to be greedy. Having seen the runups of VVOS and IXHL past 2 days, I felt this could do the same, and ended up buying worth $2k. Hopefully it doesn’t all become zero atleast. 😑
Thanks for replying. I think I got myself in a soup with trying to be greedy. Having seen the runups of VVOS and IXHL past 2 days, I felt this could do the same, and ended up buying worth $2k. Hopefully it doesn’t all become zero atleast. 😑
I follow a dude on stocktwits that gave alerts for VVOS and SNGX premarket.
This, i would’ve skimmed some even if you sold one contract. I traded VVOS , got in at 16 and sold some at 43 before close. I’m still up and only reason i havent sold completely is bc the news is substantial and its a low float. I dont set stop losses (in stocks) often which is a horrible habit but i think i just might after posting this.
Yeah VVOS...man anyone who got on that ship made SGD levels of cash
YES. I actually got into a troll war with two accounts made 18 days ago who were spamming multiple subs with $NEGG propaganda. It's why they were IP banned from WSB. ​ This is classic pump and dump hysteria. It's taking over this sub now, and it's overshadowing the people who actually have real, analytical input to real squeeze plays (Somebody had a callout for TVIC and VVOS recently and they actually squeezed). ​ This is 100% pump and dump. No analyts, just a story 3 weeks ago about the FDIC telling $NEGG if they don't keep their share price over $1.00 for 10 straight days then they'll be delisted. Partner that with the news that $NEGG will buyback $10 mil in shares over the next 2 years and everyone thinks there's something brewing. Even the short float is bogus
Real squeeze happened yesterday on VVOS
I bought VVOS in the morning and sold it in the afternoon for 110% profit, that was awesome.
Seriously. I killed it on VVOS and RDHL the last few days. Don't be stupid and buy the wrong side of the pump just to end up as someone's exit liquidity. Trading isn't a team sport, anyone who says it is is a liar who just wants your money.
I missed VVOS coz these cucks were pumping $NEGG I’m staying far away from that trash
Who among you here was lucky enough to buy VVOS before today?
I am just learning as well. I have found a couple of "live" daily YouTube channels that can work. The only thing that sucks is that there's a lag, and you still have to do a lot of research and have time to do that. They normally deal with just gappers, and pre-market seems to work best, but you have to be able to pull the trigger on selling, also called scalping. For example, this morning, one of the gappers was VVOS. I follow some Discord as well, but I don't currently pay for anything. I am learning how to use Thinkorswim, and I am also using YouTube a lot for training and live options trading. I purchase calls and puts daily, as you're doing now. I will probably go ahead and pay for trading view when my free trial ends. I just purchased a new pc with dual monitors and use the TV, tablet and phone. My goal is to make $250-$300 per day with the 5k I started with. Rule number one don't lose money!!
$HSCS looking good. $VVOS moves tomorrow (Nov. 30) and upcoming FDA catalyst 👇 https://preview.redd.it/kx5r9d3n1f3c1.jpeg?width=1170&format=pjpg&auto=webp&s=2cd6b09ec49de99048a8573f5bebbe6447c6e505
There's other things going on. Therapeutics and biomedical is were it's at. VVOS, CYTO, RDHL. Hopefully HSCS will make a run.
Holy fuck am I a regard for selling VVOS so early in the day 😩😩😩
Its VVOS. It traded wild today. Too bad I did not get in on the action.
VVOS, nice one. Good winner for me tofay aswell.
Im personally tied up completely in $VVOS Tomorrow most probably will be its last rip, hopefully to 75$
if VVOS is up we can do GME justice and follow suit...look at VVOS it is insane!!!! up 830%
Tough watching VVOS go up that much, I literally sold at 20 dollars and thought that was a good trade
VVOS not playing around either
So first RDHL, and now VVOS today. I'm going to predict CALC will soon be next...
Am I dumb or why does it say that $VVOS current price is $12.05? Isn't the price currently at $4,390?
$VVOS check the dd I post in the community.I appreciate upvotes! 
Bought CMA at $45.22 and sold at $46.43 before it pulled back to 41 the bounced back. I bought 2700 shares of WFC at $40.77 so hopefully a pop tomorrow. Also picked up 5195 of VVOS at $0.34 and 2950 of ONCS at $3.38 so not a good day for that holding.
VVOS with amazing news, will take off today
VVOS is getting sent to bed today.
2 bio tech LHDX and VVOS the rest was spy 0DTE
That is the best way to lean. It will cost you but any good education does. Listen to the Premarket talk on wallstreet bets, But I would NOT invest based on what you hear there yet. They are pretty sharp but they only talk in lingo. Google terms you hear but don't invest unless you have a clear understanding of what is going on. Do your own DD (Due Diligence) I watch about 3 or 4 different investment groups. I only invest if there is hype on a ticker in more than one group. This morning CNBC reported VVOS as a market mover, then I heard it on wallstreetbets, it was only mentioned once but those are the good on es.
Why VVOS keep halting? Let that shit rip.
VVOS keeps getting halted. Up 200%.
Not a 100 bagger, but Inspire Medical could be a 10 bagger in the future. Vivos Therapeutics (VVOS) could be a 100 bagger in the future. 45 million market cap right now. They could also end up going bankrupt. Flip a coin.
Sleep stocks, specifically sleep apnea stocks, will do quite well the next decade. I'm bullish on sleep apnea stocks. Over a billion people have sleep apnea worldwide, it goes undiagnosed in 80% of cases, and increases the risk of the leading causes of death such as heart attack, stroke, cancer, accidents, and diabetes. I personally believe this sector will do well as millennials age and awareness increases on social media. The sleep apnea devices market is expected to have a [CAGR of 6.2% from 2021 to 2028](https://markets.businessinsider.com/news/stocks/sleep-apnea-devices-market-size-worth-6-1-billion-by-2028-cagr-6-2-grand-view-research-inc-1030292947). Resmed is the world’s top CPAP manufacturer. CPAPs are the most effective treatment for sleep apnea. Resmed (RMD) is my number one holding in my portfolio. I think they have a decent chance of growing to be as large as a company like Eli Lilly within the next 10-20 years. It all depends on whether or not the US Government decides to pursue a mass screening approach for sleep apnea. This is currently being debated in the [US Preventative Services Task Force](https://www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/obstructive-sleep-apnea-adults-screening). To reiterate, about a billion people worldwide have sleep apnea and it goes undiagnosed in about 80% of cases. [Check](https://pubmed.ncbi.nlm.nih.gov/31300334/) this article on pub med. My mid cap holdings: 1) Resmed (RMD). 2) Koninklijke Phillips (PHG). Also a CPAP manufacturer. My higher risk growth plays are below: 1) Inspire Medical (INSP). They created an implant for sleep apnea, analogous to a pacemaker, to keep airways open at night. I think they have a good shot long term. 2) LivaNova (LIVN). UK equivalent of Inspire Medical, but their business is more diversified. 3) Nyxoah (NYXH). Super risky and less proven than Inspire, but less invasive of a product. Some of their startup capital came from Resmed. 4) Vivos Therapeutics (VVOS). Ultra small cap and could go bankrupt, but more risk more reward if their business pays off. They have a product that’s like a mouth guard, that expands airways to help prevent sleep apnea. They rely on dentists to diagnose and sell the product. 5) Sleep Number (SNBR). There’s some press that the company will develop more sleep tech to help with sleep apnea. My hope is that the company tries to acquire #3 or #4 to have a more integrated sleep solution. I own all these companies with Resmed and Inspire being the bulk of my portfolio. I’m bullish on the space, but recognize that some of the small caps could have issues if not out right bankruptcies. *Not financial advice. This is for entertainment/educational purposes only. Do your own research and consult with a financial professional if necessary. Be skeptical of everything that you read online.
Resmed (RMD) is my number one holding in my portfolio. I think they have a decent chance of growing to be as large as a company like Eli Lilly within the next 10-20 years. It all depends on whether or not the US Government decides to pursue a mass screening approach for sleep apnea. This is currently being debated in the US Preventative Services Task Force. To reiterate, about a billion people worldwide have sleep apnea and it goes undiagnosed in about 80% of cases. Check this article on pub med. My mid cap holdings: Resmed (RMD). Koninklijke Phillips (PHG). Also a CPAP manufacturer. My higher risk growth plays are below: Inspire Medical (INSP). They created an implant for sleep apnea, analogous to a pacemaker, to keep airways open at night. I think they have a good shot long term. LivaNova (LIVN). UK equivalent of Inspire Medical, but their business is more diversified. Nyxoah (NYXH). Super risky and less proven than Inspire, but less invasive of a product. Some of their startup capital came from Resmed. Vivos Therapeutics (VVOS). Ultra small cap and could go bankrupt, but more risk more reward if their business pays off. They have a product that’s like a mouth guard, that expands airways to help prevent sleep apnea. They rely on dentists to diagnose and sell the product. Sleep Number (SNBR). There’s some press that the company will develop more sleep tech to help with sleep apnea. My hope is that the company tries to acquire #3 or #4 to have a more integrated sleep solution. I own all these companies with Resmed and Inspire being the bulk of my portfolio. I’m bullish on the space, but recognize that some of the small caps could have issues if not out right bankruptcies. \*Not financial advice. This is for entertainment/educational purposes only. Do your own research and consult with a financial professional if necessary. Be skeptical of everything that you read online.
That’s good to hear. What they’re trying to do is intriguing to me, though they’ve had some issues the last couple of quarters. Honestly, probably was just tough for the company during COVID given their business model works through dentists, and people went to the dentist less during COVID. Quick question, were you able to have insurance cover your VVOS treatment?
VVOS patient here, it has made a significant difference in the quality of my sleep
My randomizer's worst-performing ticker, VVOS, went up nearly 50% today, damn it. I forgot to mention the 5 new tickers for this week, my bad. They're CLF, EBS, CTT, BCSF, and CHK. None have had a particularly strong start to the week, but then again few things have. Out of my personal portfolio, MMM is really the only one that hasn't gone down this week.
Watching VVOS, but not sure where it goes.
I’ve been looking at VVOS stock. Thoughts?
Currently I'm looking at VVOS. This one is around 4 dollars rn a share. The option activity for Oct 15 looks to see the largest swath of open interest in the 5 call range at 1300. There's a decent amount of resistance from anywhere above 7-10 due to the ipo last year and it popping to 15~. They have some good news and fda movement just still unsure where they will fit. Their competitors in the sleep apnea space are the cpap machine and another public company that's in the 2-300 range but they are a surgery fix/medical device implant compare to vvos using more an invisalign or braces technique to change the shape of your mouth. I like this because I have sleep apnea and it seems to be an interesting solution to a problem I directly have so I'll hold this bag till I die. My opinion is completely biased here I have shares and a feb call.
Can $VVOS go any higher? Crazy morning
$VVOS. Cause stupid shit is happening to it
Funds cleared. Buying the dip on INDI and possibly snagging some VVOS $5 calls.
I am a bot. You submitted a picture of a banned ticker, VVOS. This check will fire if you included unnecessary pictures that have bad phrases or a bad crop with news about cryptocoins, for example. Repost with the useless pictures omitted if you did that. Yell at /u/zjz if it's above 1.25 billion-ish market cap and not related to crypto/pennies/OTC/SPACs.
VVOS- Vivos. They make oral correction devices to fix sleep apnea. Kinda like braces to eliminate snoring. They have increasing revenues and a decent little moat.